Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Axel Linke

Showing results (371-380 of 444) with videos related to

Pageof 45
Sort By:
JAMA Cardiology|February 28, 2019
Two-Year Outcomes After Transcatheter Aortic Valve Replacement With Mechanical vs Self-expanding Valves: The REPRISE III Randomized Clinical TrialMichael J Reardon, Ted E Feldman, Christopher U Meduri, et al.
The New England Journal of Medicine|June 18, 2010
Comparison of zotarolimus-eluting and everolimus-eluting coronary stentsPatrick W Serruys, Sigmund Silber, Scot Garg, et al.
Journal of the American College of Cardiology|November 12, 2025
Sex-Specific Microaxial Flow Pump Use and Outcomes in Infarct-Related Cardiogenic Shock in the DanGer Shock TrialNorman Mangner, Rasmus Paulin Beske, Christian Hassager, et al.
JACC. Cardiovascular Interventions|February 11, 2026
Bleeding in Patients With Infarct-Related Cardiogenic Shock: A DanGer Shock SubstudyRikke Sørensen, Jacob Eifer Møller, Christophe Vandenbriele, et al.
European Heart Journal|March 12, 2026
Mechanical circulatory support center volume and outcomes in infarct-related cardiogenic shock: the ECLS-SHOCK trialMohammad Abumayyaleh, Uwe Zeymer, Tienush Rassaf, et al.
JAMA Cardiology|August 30, 2025
Systolic Blood Pressure and Microaxial Flow Pump-Associated Survival in Infarct-Related Cardiogenic Shock: A Post Hoc Analysis of the DanGer Shock Randomized Clinical TrialAstrid Duus Mikkelsen, Rasmus Paulin Beske, Lisette Okkels Jensen, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|May 25, 2021
Thirty-day outcomes of the Cardioband tricuspid system for patients with symptomatic functional tricuspid regurgitation: The TriBAND studyGeorg Nickenig, Kai P Friedrichs, Stephan Baldus, et al.
Journal of the American College of Cardiology|June 25, 2025
Effect of Microaxial Flow Pump on Hemodynamics in STEMI-Related Cardiogenic ShockJacob Eifer Møller, Rasmus Paulin Beske, Lisette Okkels Jensen, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|December 10, 2015
First generation versus second generation drug-eluting stents for the treatment of bifurcations: 5-year follow-up of the LEADERS all-comers randomized trialMaik J Grundeken, Joanna J Wykrzykowska, Yuki Ishibashi, et al.
JAMA Cardiology|October 27, 2024
Microaxial Flow Pump Hemodynamic and Metabolic Effects in Infarct-Related Cardiogenic Shock: A Substudy of the DanGer Shock Randomized Clinical TrialNanna Louise Junker Udesen, Rasmus Paulin Beske, Christian Hassager, et al.
Pageof 45

Showing results (371-380 of 444) with videos related to

Sort By:
Pageof 45
JAMA Cardiology|February 28, 2019
Two-Year Outcomes After Transcatheter Aortic Valve Replacement With Mechanical vs Self-expanding Valves: The REPRISE III Randomized Clinical TrialMichael J Reardon, Ted E Feldman, Christopher U Meduri, et al.
The New England Journal of Medicine|June 18, 2010
Comparison of zotarolimus-eluting and everolimus-eluting coronary stentsPatrick W Serruys, Sigmund Silber, Scot Garg, et al.
Journal of the American College of Cardiology|November 12, 2025
Sex-Specific Microaxial Flow Pump Use and Outcomes in Infarct-Related Cardiogenic Shock in the DanGer Shock TrialNorman Mangner, Rasmus Paulin Beske, Christian Hassager, et al.
JACC. Cardiovascular Interventions|February 11, 2026
Bleeding in Patients With Infarct-Related Cardiogenic Shock: A DanGer Shock SubstudyRikke Sørensen, Jacob Eifer Møller, Christophe Vandenbriele, et al.
European Heart Journal|March 12, 2026
Mechanical circulatory support center volume and outcomes in infarct-related cardiogenic shock: the ECLS-SHOCK trialMohammad Abumayyaleh, Uwe Zeymer, Tienush Rassaf, et al.
JAMA Cardiology|August 30, 2025
Systolic Blood Pressure and Microaxial Flow Pump-Associated Survival in Infarct-Related Cardiogenic Shock: A Post Hoc Analysis of the DanGer Shock Randomized Clinical TrialAstrid Duus Mikkelsen, Rasmus Paulin Beske, Lisette Okkels Jensen, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|May 25, 2021
Thirty-day outcomes of the Cardioband tricuspid system for patients with symptomatic functional tricuspid regurgitation: The TriBAND studyGeorg Nickenig, Kai P Friedrichs, Stephan Baldus, et al.
Journal of the American College of Cardiology|June 25, 2025
Effect of Microaxial Flow Pump on Hemodynamics in STEMI-Related Cardiogenic ShockJacob Eifer Møller, Rasmus Paulin Beske, Lisette Okkels Jensen, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|December 10, 2015
First generation versus second generation drug-eluting stents for the treatment of bifurcations: 5-year follow-up of the LEADERS all-comers randomized trialMaik J Grundeken, Joanna J Wykrzykowska, Yuki Ishibashi, et al.
JAMA Cardiology|October 27, 2024
Microaxial Flow Pump Hemodynamic and Metabolic Effects in Infarct-Related Cardiogenic Shock: A Substudy of the DanGer Shock Randomized Clinical TrialNanna Louise Junker Udesen, Rasmus Paulin Beske, Christian Hassager, et al.
Pageof 45